当前位置:首页 - 行情中心 - 沃华医药(002107) - 财务分析 - 现金流量表

沃华医药

(002107)

  

流通市值:36.17亿  总市值:36.54亿
流通股本:5.71亿   总股本:5.77亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金448,628,127.59254,343,800.74901,655,983.68689,523,102.51
  收到其他与经营活动有关的现金5,602,513.812,637,506.0218,412,574.399,035,349.32
  经营活动现金流入小计454,230,641.4256,981,306.76920,068,558.07698,558,451.83
  购买商品、接受劳务支付的现金77,155,760.1935,923,956.37144,453,343.17104,260,984.12
  支付给职工以及为职工支付的现金84,199,299.9245,414,042.37164,025,095.58123,980,413.74
  支付的各项税费55,927,843.6728,917,159.49111,891,470.1480,789,964.45
  支付其他与经营活动有关的现金155,580,235.1479,082,777.32371,173,033.18280,825,836.68
  经营活动现金流出小计372,863,138.92189,337,935.55791,542,942.07589,857,198.99
  经营活动产生的现金流量净额81,367,502.4867,643,371.21128,525,616108,701,252.84
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额--14,653,57214,650,272
  处置子公司及其他营业单位收到的现金净额--820,000820,000
  投资活动现金流入的平衡项目--00
  投资活动现金流入小计--15,473,57215,470,272
  购建固定资产、无形资产和其他长期资产支付的现金1,095,065.21717,575.21864,503.16546,677.53
  投资活动现金流出小计1,095,065.21717,575.21864,503.16546,677.53
  投资活动产生的现金流量净额-1,095,065.21-717,575.2114,609,068.8414,923,594.47
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金87,800,601.687,800,601.690,825,15273,185,152
  其中:子公司支付给少数股东的股利、利润3,528,0003,528,00021,560,0003,920,000
  支付其他与筹资活动有关的现金383,684.88101,088.331,147,932.68802,679.4
  筹资活动现金流出小计88,184,286.4887,901,689.9391,973,084.6873,987,831.4
  筹资活动产生的现金流量净额-88,184,286.48-87,901,689.93-91,973,084.68-73,987,831.4
五、现金及现金等价物净增加额-7,911,849.21-20,975,893.9351,161,600.1649,637,015.91
  加:期初现金及现金等价物余额394,037,806.06394,037,806.06342,876,205.9342,876,205.9
  期末现金及现金等价物余额386,125,956.85373,061,912.13394,037,806.06392,513,221.81
补充资料:
  净利润71,033,118.92-88,791,071.62-
  资产减值准备542,347.16-1,950,661.77-
  固定资产和投资性房地产折旧14,462,850.5-29,205,157.78-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧14,462,850.5-29,205,157.78-
  无形资产摊销653,887.8-1,368,526.28-
  处置固定资产、无形资产和其他长期资产的损失-1,502.59---
  固定资产报废损失2,070.55-170,469.99-
  财务费用18,767.58-62,306.1-
  投资损失---1,763,146.58-
  递延所得税-160,347.5-205,752.52-
  其中:递延所得税资产减少32,552.5-679,115.63-
    递延所得税负债增加-192,900--473,363.11-
  存货的减少-16,451,333.54-11,720,945.6-
  经营性应收项目的减少15,323,607.82-3,301,923.17-
  经营性应付项目的增加-3,791,799.9--4,306,270.2-
  现金的期末余额386,125,956.85-394,037,806.06-
  减:现金的期初余额394,037,806.06-342,876,205.9-
  现金及现金等价物的净增加额-7,911,849.21-51,161,600.16-
公告日期2026-07-162026-04-082026-01-202025-10-18
审计意见(境内)标准无保留意见
TOP↑